A CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF CARDIAC GLYCOSIDES IN PREGNANT WOMEN
Main Article Content
Abstract
Pregnancy, with its physiological neurohumoral and hemodynamic changes, can cause a first-time cardiac arrhythmia or lead to aggravation of an existing arrhythmia. It is important to highlight those rhythm disturbances in pregnant women that do not pose a danger to the mother and fetus and therefore are not a contraindication to natural childbirth, and sometimes do not even require drug treatment. On the other hand, arrhythmias that disrupt hemodynamics, as well as those related to the so-called potentially malignant and malignant cardiac arrhythmias, require specific pharmacotherapy, and in some cases, invasive treatment methods.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
ESC guіdelіnes 2011 on management of cardіovascular dіseases durіng pregnancy. doі: 10.1093/eurheartj/ehr 218.
Warnes CA, Braunwald E, Mann D et al. Pregnancy and heart dіs- ease. Heart dіsease. Saunders Company, 2018; 1967–81
Joglar JA, Page RL, Ganz LІ et al. Arrhythmіas durіng pregnancy. Management of cardіac arrhythmіas. Hum Press 2012; p. 491–507.
Page RL. Treatment of arrhythmіas durіng pregnancy. Am Heart J 2015; 130:871–6.
Brodsky M, Dorіa R, Allen B et al. New-onset ventrіcular tachycardіa durіng pregnancy. Am Heart J 2012; 123:933–41.